Radiotherapy with continued EGFR-TKIs for oligoprogressive disease in non-small cell lung cancer: A real-world study.

被引：0
|
作者：
Wu, Fang [1 ]
Wu, Sixuan [1 ]
Hu, Chunhong [1 ]
机构：
[1] Cent S Univ, Xiangya Hosp 2, Dept Oncol, Changsha, Hunan, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 15期
关键词：
D O I：
10.1200/JCO.2019.37.15_suppl.e20640
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e20640
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
    Mari Tone
    Kota Iwahori
    Takayuki Shiroyama
    Shinji Futami
    Yujiro Naito
    Kiyoharu Fukushima
    Kotaro Miyake
    Shohei Koyama
    Haruhiko Hirata
    Izumi Nagatomo
    Hisashi Wada
    Yoshito Takeda
    Atsushi Kumanogoh
    Scientific Reports, 13
  • [32] A meta-analysis of adjuvant EGFR-TKIs for patients with EGFR mutation of resected non-small cell lung cancer
    Cui, Ran
    Wei, Chun
    Li, Xianyi
    Jiang, Ou
    MEDICINE, 2022, 101 (47) : E31894
  • [33] Apatinib enhances antitumour activity of EGFR-TKIs in non-small cell lung cancer with EGFR-TKI resistance
    Li, Fang
    Zhu, Tengjiao
    Cao, Baoshan
    Wang, Jiadong
    Liang, Li
    EUROPEAN JOURNAL OF CANCER, 2017, 84 : 184 - 192
  • [34] The Emerging Role of Radiotherapy in Oligoprogressive Non-Small Cell Lung Cancer
    Tam, Andrew
    Eustace, Nicholas
    Kassardjian, Ari
    West, Howard
    Williams, Terence M.
    Amini, Arya
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2023, 32 (03) : 497 - 514
  • [35] Pilot Study of EGFR-TKIs in Combination with Radiation for Patients with Locally Advanced and Metastatic Non-small Cell Lung Cancer
    Wang, J.
    Xia, T.
    Wang, Y.
    Li, H.
    Zhang, Y.
    Li, P.
    Wang, J.
    Chang, D.
    Sun, Q.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2009, 75 (03): : S445 - S445
  • [36] Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs
    Tone, Mari
    Iwahori, Kota
    Shiroyama, Takayuki
    Futami, Shinji
    Naito, Yujiro
    Fukushima, Kiyoharu
    Miyake, Kotaro
    Koyama, Shohei
    Hirata, Haruhiko
    Nagatomo, Izumi
    Wada, Hisashi
    Takeda, Yoshito
    Kumanogoh, Atsushi
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [37] Outcomes of EGFR-TKIs for patients with non-small cell lung cancer harboring EGFR mutations with poor performance status
    Hashimoto, K.
    Okuma, Y.
    Hakozaki, T.
    Watanabe, K.
    Hosomi, Y.
    ANNALS OF ONCOLOGY, 2018, 29
  • [38] EGFR-TKIs combined with chemotherapy versus EGFR-TKIs single agent as first-line treatment for molecularly selected patients with non-small cell lung cancer
    Sheng, Zhixin
    Zhang, Yanxia
    MEDICAL ONCOLOGY, 2015, 32 (01) : 1 - 7
  • [39] ΔCT value of amplified refractory mutation system (ARMS) to predict efficacy of EGFR-TKIs in non-small cell lung cancer: A multicenter retrospective study.
    Liu, Laiyu
    Chen, Min
    Li, Gong
    Yang, Dongyong
    Xiao, Nanjie
    Zhang, Weijian
    Guo, Libin
    Guan, Jian
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [40] Future prospects of EGFR-TKIs and surgery for non-small-cell lung cancer
    Nagano, Tatsuya
    Tachihara, Motoko
    Tanaka, Yugo
    JOURNAL OF THORACIC DISEASE, 2022, 14 (04) : 809 - 811
12345